Status:

UNKNOWN

´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2.

Lead Sponsor:

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Collaborating Sponsors:

Instituto de Salud Carlos III

Consorci Hospitalari de Vic

Conditions:

Diabetes Mellitus, Type II

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The objective of the study is measuring the impact of a ´sit less, move more' mHealth intervention at work on the glycaemic control and anthropometric profile of office employees with diabetes type 2 ...

Detailed Description

A double-blind randomized controlled trial. Seven Primary Care Centers from Spain (n=5 Catalonia, n=2 Madrid), 2 hospitals (n=1 Catalonia, n=1 Madrid) and 2 companies (occupational health services; n=...

Eligibility Criteria

Inclusion

  • DM2 diagnosed office employees according to international criteria.
  • Doing sedentary tasks during at least a 55% of their daily work schedule (according to the Occupational Sedentary and Physical Activity Questionnaire: OSPAQ \>55%).
  • Having a cellphone .
  • Having a minimum work contract of 18.5 hours per week.
  • Being able to get up from the chair or to walk by themselves (without any help).

Exclusion

  • Not having a cellphone.
  • Having some pathology/disability/injury which changes their ability and capacity to walk or getting up from the chair.
  • Doing less than a 55% of the daily tasks in a sitting position according to the OSPAQ questionnaire.

Key Trial Info

Start Date :

March 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2021

Estimated Enrollment :

368 Patients enrolled

Trial Details

Trial ID

NCT04092738

Start Date

March 4 2019

End Date

September 1 2021

Last Update

September 17 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IDIAP Jordi Gol

Barcelona, Spain, 08007

´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2. | DecenTrialz